Standard Essential Patent (SEP) Losing its Value -Report

Have you ever questioned what number of billions does a Standard Essential Patent (SEP) fetch to a SEP owner? The answer is billions. The licensing fees associated with a SEP generates a big quantity of revenue for the SEP owner. 

But what if the SEP unknowingly loses its essentiality? The upward curve of sales will drop significantly if the SEP loses its value. To avoid this situation, we’re right here to talk about a number of the elements responsible for the lack of the essentiality of a SEP patent. Before that, let us first talk about how a patent is asserted as a Standard Essential Patent (SEP).

Possible Factors Which Can Lead SEPs To Non-SEPs 

  • Claim Amendments During Prosecution/Re-examination
  • Standard Specification Revision

Having detailed research about the threads & Opportunity may lead you to a better position to target.

  • Chemical/Sequence Search
  • Technology Scouting
  • Portfolio Analysis
  • Patent/Technology Landscape
  • Top Players in the market
Report

Standard Essential Patent (SEP) Losing its Value

Standard Essential Patent (SEP) Losing its Value

Download the Report

Send download link to:

About TTC
We’ve constantly identified the value of new technology carried out by our pretty skilled executive crew with backgrounds as our professionals. Like the IP professionals we empower, our starvation for development is never-ending. We IMPROVISE, ADAPT, and IMPLEMENT in a strategic manner.
 
You also can Contact Us to set up a consultation.
 
TT Consultants offers a range of efficient, high-quality solutions for your intellectual property management ranging from Patentability SearchInvalidation SearchFTO (Freedom to Operate)Patent Portfolio OptimizationPatent MonitoringPatent Infringement SearchPatent Drafting & Illustrations, and much more. We provide both law firms and corporations in many industries with turnkey solutions.
Insights

More Related Articles

protein sequence analysis biotechnology

Sequence-Based Freedom-to-Operate for a Clinical-Stage Antibody

The Patent That Looked Non-Essential – Until We Decoded the Math

EV Patent Infringement Analysis for 3,500+ Patents with TT Consultants

How a Global EV Giant Converted 3,500+ Patents into Validated Infringement Intelligence in 6 Weeks